Phospho-MEF2C (Ser396) Antibody

What is MEF2C and why is phosphorylation at Ser396 significant?

MEF2C is a transcription activator belonging to the MADS family that binds specifically to the MEF2 element present in regulatory regions of many muscle-specific genes. The phosphorylation of MEF2C at Ser396 represents an important post-translational modification that regulates its activity. MEF2C controls cardiac morphogenesis and myogenesis while also playing crucial roles in vascular development, neurogenesis, and cortical architecture development . Phosphorylation at Ser396 affects DNA binding affinity and transactivation capacity, making it a critical regulatory mechanism in multiple developmental and physiological processes . The molecular weight of MEF2C is approximately 51 kDa, though this may vary due to post-translational modifications .

Which experimental applications are most suitable for Phospho-MEF2C (Ser396) antibodies?

Phospho-MEF2C (Ser396) antibodies have been validated for multiple experimental applications:

• Western Blot (WB): The most common application, typically using dilutions of 1:500-1:2000

• Enzyme-Linked Immunosorbent Assay (ELISA): High sensitivity detection, typically at 1:10000 dilution

• Immunohistochemistry (IHC): Tissue localization studies at 1:100-1:300 dilution

• Immunofluorescence (IF): Cellular localization studies at 1:50-200 dilution

When selecting an application, consider the sensitivity requirements, sample type, and whether you need quantitative (ELISA, WB) or qualitative (IHC, IF) data. Most commercially available antibodies have been biologically validated for detecting endogenous levels of phosphorylated MEF2C at Ser396 .

What is the specificity profile of typical Phospho-MEF2C (Ser396) antibodies?

Phospho-MEF2C (Ser396) antibodies are engineered to specifically detect MEF2C only when phosphorylated at the Ser396 residue. These antibodies are typically raised against synthetic phosphorylated peptides derived from human MEF2C around the phosphorylation site of Ser396 . The immunogens usually span amino acids 362-411 of the human MEF2C protein sequence . The specificity can be demonstrated through peptide competition assays, where pre-incubation with the phospho-peptide blocks antibody binding, as shown in Western blot analyses of cos-7 cell extracts . Most commercially available antibodies show reactivity with human and mouse samples due to high sequence conservation in this region .

What are the optimal experimental conditions for Western blot detection of phospho-MEF2C (Ser396)?

For optimal Western blot detection of phospho-MEF2C (Ser396):

• Sample preparation: Extract proteins from cells using proper lysis buffers containing phosphatase inhibitors to preserve phosphorylation status.

• Protein loading: Use 25μg of protein per lane for adequate signal detection .

• Blocking: 3% BSA is recommended over milk, as milk contains phosphoproteins that may increase background .

• Primary antibody dilution: Use at 1:1000 dilution for most applications .

• Secondary antibody: HRP-conjugated anti-rabbit IgG at 1:10000 dilution .

• Controls: Include phosphatase-treated samples as negative controls.

• Cell treatments: Use serum starvation followed by stimulation protocols (e.g., 10% FBS or 100ng/mL EGF for 30 minutes) to modulate phosphorylation levels, as demonstrated with K-562 and MCF-7 cell lines .

These conditions have been validated through experimental protocols showing specific detection of the approximately 51 kDa phosphorylated MEF2C protein in stimulated cell lines .

How should researchers induce or modulate MEF2C phosphorylation at Ser396 in cellular models?

To effectively induce or modulate MEF2C phosphorylation at Ser396:

• Serum starvation: Subject cells to overnight serum starvation to reduce basal phosphorylation levels .

• Growth factor stimulation:

  • Treat with 10% FBS for 30 minutes (validated in K-562 cells)

  • Apply EGF (100ng/mL) for 30 minutes (validated in MCF-7 cells)

• BCR stimulation: For B-cell studies, as MEF2C is required for B-cell survival and proliferation in response to BCR stimulation .

• Kinase activators/inhibitors: Use specific kinase activators or inhibitors targeting pathways known to phosphorylate MEF2C.

The phosphorylation status should be verified using the phospho-specific antibody in parallel with a total MEF2C antibody to normalize for protein expression levels. The cellular localization should also be monitored, as MEF2C shuttles between the nucleus and cytoplasm/sarcoplasm depending on its phosphorylation state .

What are the recommended storage and handling protocols for phospho-MEF2C (Ser396) antibodies?

To maintain antibody integrity and performance:

• Storage temperature: Store antibodies at -20°C or -80°C for long-term storage .

• Formulation: Most antibodies are supplied in PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide .

• Avoid freeze-thaw cycles: Aliquot antibodies upon receipt to minimize repeated freeze-thaw cycles.

• Working dilutions: Prepare working dilutions immediately before use and discard unused portions.

• Shelf life: Typical stability is approximately one year when stored properly at -20°C .

• Handling: Wear gloves when handling antibodies to prevent contamination.

• Centrifugation: Briefly centrifuge vials before opening to collect all material at the bottom.

Proper storage and handling ensure optimal antibody performance and reproducibility in experimental applications over the recommended shelf life period of one year .

How does phosphorylation at Ser396 affect MEF2C function compared to other post-translational modifications?

MEF2C undergoes multiple post-translational modifications that collectively regulate its activity:

• Ser396 phosphorylation: Affects transcriptional activity and possibly subcellular localization .

• Acetylation: Acetylation on Lys-4 by p300 increases DNA binding and transactivation, particularly in differentiating myocytes .

• Domain-specific effects: MEF2C contains a beta domain that enhances transcriptional activity when present. Some isoforms lacking this domain show altered activity profiles .

• Repressor domain: Isoforms 3 and 4, which lack the repressor domain, demonstrate higher transcriptional activity compared to isoforms 1 and 2 .

The interplay between Ser396 phosphorylation and other modifications creates a complex regulatory network. Phosphorylation may affect protein-protein interactions, DNA binding affinity, nuclear localization, and transcriptional activation potential. Understanding these relationships requires combinatorial analysis using antibodies against different modified forms of MEF2C and functional transcription assays .

What are the key considerations when interpreting phospho-MEF2C (Ser396) signals across different tissue types?

When analyzing phospho-MEF2C (Ser396) across different tissues, researchers should consider:

These factors necessitate careful experimental design with appropriate controls and validation across multiple techniques when comparing phospho-MEF2C levels between different tissue types .

How can researchers differentiate between specific phospho-MEF2C (Ser396) signal and potential cross-reactivity?

To ensure specificity and minimize cross-reactivity concerns:

• Peptide competition assays: Pre-incubate the antibody with antigen-specific phosphopeptide before immunodetection. This should abolish specific signals, as demonstrated in cos-7 cell extracts .

• Phosphatase treatment controls: Treat half of your sample with lambda phosphatase before immunoblotting to confirm phosphorylation-dependent detection.

• Knockout/knockdown controls: Use MEF2C knockout or knockdown samples as negative controls to confirm signal specificity.

• Parallel detection: Use multiple antibodies from different sources targeting the same phosphorylation site to confirm results.

• Recombinant protein standards: Include phosphorylated and non-phosphorylated recombinant MEF2C proteins as controls.

• Signal validation: Confirm that the observed band appears at the expected molecular weight (approximately 51 kDa) .

• Multiple techniques: Validate findings using complementary techniques like mass spectrometry for phosphorylation site confirmation.

These approaches collectively strengthen confidence in the specificity of detected phospho-MEF2C (Ser396) signals .

What are common challenges in detecting phospho-MEF2C (Ser396) and their solutions?

These issues can be systematically addressed through careful optimization of experimental conditions and inclusion of appropriate controls .

How should researchers compare results across different phospho-MEF2C (Ser396) antibody sources?

When comparing results from different phospho-MEF2C (Ser396) antibody sources:

• Epitope comparison: Review the immunogen information to ensure antibodies target the same phospho-epitope. Most are raised against synthetic phosphopeptides surrounding Ser396 .

• Validation methods: Compare the validation methods used by manufacturers. Biological validation through Western blot of stimulated cell lines provides stronger evidence than ELISA alone .

• Side-by-side testing: Run parallel experiments using antibodies from different sources with the same samples and protocols.

• Standardization:

  • Use recombinant phosphorylated standards to calibrate detection sensitivity

  • Include the same positive controls (e.g., EGF-stimulated MCF-7 cells)

  • Apply identical dilutions when possible or adjust based on manufacturer recommendations

• Cross-validation: Confirm key findings with at least two independent antibody sources.

• Documentation: Record lot numbers, as antibody performance can vary between production batches.

This methodical approach allows meaningful comparisons while accounting for potential variations in antibody characteristics from different suppliers .

What research models best demonstrate MEF2C Ser396 phosphorylation dynamics?

Based on the search results, several research models effectively demonstrate MEF2C Ser396 phosphorylation dynamics:

• Cell line models:

  • K-562 cells: Respond to serum stimulation (10% FBS for 30 minutes) after overnight starvation

  • MCF-7 cells: Show robust phosphorylation after EGF treatment (100 ng/mL for 30 minutes)

  • Cos-7 cells: Demonstrate detectable phospho-MEF2C levels suitable for peptide competition assays

• Tissue models:

  • Brain tissue: MEF2C is highly expressed in brain, making it valuable for studying neurogenesis and cortical architecture development

  • Skeletal muscle: Another site of high MEF2C expression, useful for myogenesis studies

  • Cardiac tissue: Important for studying MEF2C's role in cardiac morphogenesis

  • Vascular tissue: Relevant for MEF2C's involvement in vascular development

• B-cell models: For investigating MEF2C's role in B-cell survival, proliferation, and antibody responses

• Developmental models: Studies during early postnatal development when MEF2C expression is highest

These models provide complementary systems for investigating the physiological significance of MEF2C Ser396 phosphorylation in different biological contexts .

How can phospho-MEF2C (Ser396) antibodies be integrated into multi-parameter analyses?

Phospho-MEF2C (Ser396) antibodies can be effectively integrated into multi-parameter analyses through:

• Multiplexed immunofluorescence:

  • Combine phospho-MEF2C (Ser396) antibodies with antibodies against total MEF2C and other signaling proteins

  • Use species-specific secondary antibodies with distinct fluorophores

  • Include cellular markers to identify specific cell populations

• Sequential immunoblotting:

  • Strip and reprobe membranes to detect multiple phosphorylation sites or related proteins

  • Use differentially labeled secondary antibodies for simultaneous detection

• Phosphorylation networks:

  • Pair with antibodies against upstream kinases or downstream targets

  • Create signaling network maps by quantifying multiple phosphorylation events

• Flow cytometry:

  • Combine with cell surface markers for population-specific phosphorylation analysis

  • Use with cell cycle markers to correlate phosphorylation with cell cycle phases

• ChIP-seq integration:

  • Correlate MEF2C phosphorylation status with chromatin binding profiles

  • Identify phosphorylation-dependent target genes

• Spatial analysis in tissue:

  • Use multiplexed IHC to map phospho-MEF2C distribution relative to anatomical features

  • Correlate with markers of cell activation, differentiation, or stress

These approaches provide a more comprehensive understanding of how MEF2C phosphorylation integrates with broader cellular signaling networks and functions .

What emerging research areas could benefit from phospho-MEF2C (Ser396) antibody applications?

Several emerging research areas could benefit significantly from phospho-MEF2C (Ser396) antibody applications:

• Neurodevelopmental disorders: MEF2C is crucial for normal neuronal development, distribution, and electrical activity in the neocortex . Studying its phosphorylation could provide insights into disorders like autism or intellectual disability.

• Learning and memory mechanisms: MEF2C plays an essential role in hippocampal-dependent learning and memory by regulating excitatory synapses . Phosphorylation-specific antibodies could help map these processes at the molecular level.

• Cardiac regeneration: Given MEF2C's role in cardiac morphogenesis , investigating phosphorylation dynamics could inform regenerative medicine approaches for heart disease.

• B-cell immunotherapy development: MEF2C is required for B-cell survival and proliferation . Understanding phosphorylation regulation could improve immunotherapy design.

• Vascular biology and angiogenesis: MEF2C's involvement in vascular development suggests its phosphorylation may regulate angiogenesis, relevant to cancer and ischemic diseases.

• Skeletal muscle regeneration: As a key regulator of myogenesis , phosphorylated MEF2C could be a biomarker or target in muscle wasting disorders.

• Epigenetic regulation: Investigating how phosphorylation affects MEF2C's interaction with chromatin modifiers could reveal novel regulatory mechanisms.

These research directions represent promising applications of phospho-MEF2C (Ser396) antibodies beyond traditional protein detection .

What are the key recommendations for generating reproducible phospho-MEF2C (Ser396) data?

To ensure reproducible phospho-MEF2C (Ser396) data, researchers should adhere to these key recommendations:

• Standardized protocols:

  • Maintain consistent cell culture conditions and passage numbers

  • Standardize stimulation protocols (e.g., serum starvation followed by precise stimulation timing)

  • Use freshly prepared buffers with phosphatase inhibitors

• Rigorous controls:

  • Include phosphatase-treated negative controls

  • Use positive controls (e.g., EGF-stimulated MCF-7 cells)

  • Run total MEF2C detection in parallel for normalization

• Antibody validation:

  • Perform peptide competition assays to confirm specificity

  • Validate new antibody lots before use in critical experiments

  • Maintain consistent antibody sources and catalog numbers across studies

• Quantification practices:

  • Use appropriate loading controls

  • Apply statistical analysis to replicate experiments

  • Report both raw and normalized phosphorylation levels

• Technical considerations:

  • Use BSA instead of milk for blocking in phospho-protein detection

  • Maintain proper sample storage conditions (-20°C or -80°C)

  • Document detailed methodological information in publications

• Cross-validation:

  • Verify key findings with multiple techniques (WB, IHC, IF)

  • Consider phospho-enrichment methods for low-abundance detection

Adherence to these practices will significantly enhance data reproducibility and reliability in phospho-MEF2C research .

How should researchers interpret the functional significance of changes in MEF2C Ser396 phosphorylation?

Interpreting the functional significance of changes in MEF2C Ser396 phosphorylation requires a multifaceted approach:

• Correlation with transcriptional activity:

  • Measure MEF2C target gene expression in parallel with phosphorylation changes

  • Use reporter gene assays with MEF2 response elements to assess transcriptional function

  • Compare phospho-mimetic (S396D/E) and phospho-null (S396A) mutants

• Contextual interpretation:

  • Consider cell/tissue type context, as MEF2C functions differ between muscle, brain, and immune cells

  • Evaluate developmental timing, as MEF2C expression and function change throughout development

  • Assess other MEF2C modifications occurring simultaneously (acetylation, other phosphorylation sites)

• Protein interactions:

  • Determine if Ser396 phosphorylation alters protein-protein interactions

  • Investigate coactivator/corepressor recruitment to MEF2C complexes

  • Examine changes in MEF2C dimerization or complex formation

• Subcellular localization:

  • Analyze if phosphorylation affects nuclear/cytoplasmic distribution

  • Assess chromatin association through ChIP assays

• Physiological responses:

  • Link phosphorylation changes to functional outcomes in relevant processes:

    • Muscle differentiation

    • Neuronal development

    • Vascular formation

    • B-cell responses